Log In
BCIQ
Print this Print this
 

PT30

  Manage Alerts
Collapse Summary General Information
Company Shield Therapeutics plc
DescriptionIV iron
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat iron deficiency anemia (IAD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today